Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Annals of the New York Academy of Sciences|December 31, 2005
Alterations in DNA repair gene expression under hypoxia: elucidating the mechanisms of hypoxia-induced genetic instabilityRanjit S Bindra, Paul J Schaffer, Alice Meng, et al.
Molecular and Cellular Biology|September 16, 2004
Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cellsRanjit S Bindra, Paul J Schaffer, Alice Meng, et al.
The Prostate|April 8, 2009
High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancerAdrian S Ishkanian, Chad A Mallof, James Ho, et al.
European Urology Oncology|July 2, 2020
Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate CancerHarry C Brastianos, Jure Murgic, Adriana Salcedo, et al.
The Prostate|January 4, 2012
Allelic loss of the loci containing the androgen synthesis gene, StAR, is prognostic for relapse in intermediate-risk prostate cancerJennifer A Locke, Gaetano Zafarana, Chad A Malloff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2011
NKX3.1 haploinsufficiency is prognostic for prostate cancer relapse following surgery or image-guided radiotherapyJennifer A Locke, Gaetano Zafarana, Adrian S Ishkanian, et al.
Cancer|January 28, 2012
Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapyGaetano Zafarana, Adrian S Ishkanian, Chad A Malloff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repairAlan Dal Pra, Emilie Lalonde, Jenna Sykes, et al.
European Urology|November 6, 2016
Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate TumorsEmilie Lalonde, Rached Alkallas, Melvin Lee Kiang Chua, et al.
Nature Communications|January 10, 2017
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectoriesRenea A Taylor, Michael Fraser, Julie Livingstone, et al.
Pageof 3